Welcome Guest
Sign In
Register
Products
Popular Categories
Antibody Search
ELISA Kit Search
Biomolecules
Flow Cytometers
Thermal Cyclers
Microscopes
Transfection Reagents
Featured Products
New Products
Research Areas
ELISA
Western Blot
3D Cell Culture
Digital PCR
Quantitative PCR
Cell and Gene Therapy
In Vivo Models
Resources
eBooks
Bench Tips
Tech Insights
Editorial Articles
News
Product Reviews
Future Lab
White Papers
Infographics
Events
Promotions
Multimedia
Biocompare Webinars
Technologies Transforming Precision Medicine
Immunotherapy
Reproducibility
Transformative Technologies
Podcasts
Bench Tip Videos
All Videos and Webinars
Life Science Webinars
Write a Review
Antibodies
Kits/Reagents
Equipment
Services
Register
Sign In
Biocompare
Products
Protein Biochemistry
Chemicals and Reagents
Pivanex
Pivanex from MedChemExpress
Be the first to write a review!
Citations:
(4)
Supplier Page
Supplier Page from
MedChemExpress for
Pivanex
Get Pricing
Description
Pivanex (AN-9), a derivative of Butyric acid, is an orally active
HDAC
inhibitor. Pivanex down-regulates
bcr-abl
protein and enhances
apoptosis
. Pivanex has antimetastic and antiangiogenic properties
Product Specs
Company Info
Citations
Reviews
Product Specs
Item
Pivanex
Company
MedChemExpress
Price
$38.00
Supplier Page
View Company Product Page
Catalog Number
HY-120508
Quantity
10 mM * 1 mL
Applications
Bioactivity, Structure and function analysis, ELISA, SDS-PAGE, Western blotting
Type
Chemical
Research Area
Inflammation/Immunology; Cancer
Add to Compare List
MedChemExpress
1 Deer Park Drive, Suite F
MONMOUTH JUNCTION
,
NJ
08852
United States
Phone
: US Tel: 609-228-6898
US Fax: 609-228-5909
EU Tel: +4686500910
Email: sales@medchemexpress.com
eu.sales@MedChemExpress.com
Company Profile
Website:
medchemexpress.com
Citations (4)
(1)
Effect of the Butyrate Prodrug Pivaloyloxymethyl Butyrate (AN9) on a Mouse Model for Spinal Muscular Atrophy
Journal of neuromuscular diseases
November 29, 2016
Edwards JD, Butchbach ME.
(2)
Pivanex, a histone deacetylase inhibitor, induces changes in BCR-ABL expression and when combined with STI571, acts synergistically in a chronic myelocytic leukemia cell line
Leukemia research
August 1, 2007
Rabizadeh E, Merkin V, Belyaeva I, Shaklai M, Zimra Y.
(3)
The histone deacetylase inhibitor AN-9 has selective toxicity to acute leukemia and drug-resistant primary leukemia and cancer cell lines
Blood
November 1, 2002
Batova A, Shao LE, Diccianni MB, Yu AL, Tanaka T, Rephaeli A, Nudelman A, Yu J.
(4)
The Open University; self-instruction in professional education
Nursing times
September 9, 1976
Lee CM.
<<
<
>
>>
Reviews
Be the First to Write a Review!
Pivanex from MedChemExpress
Supplier Page
View Company Product Page
$38.00
Product Specs
Company Info
Citations
Reviews
Back To Top